This trial is testing a new way to treat medulloblastoma that is based on the molecular characteristics of each person's tumor.
1 Primary · 1 Secondary · Reporting Duration: Up to 2 years
Experimental Treatment
10 Total Participants · 1 Treatment Group
Primary Treatment: Specialized Tumor Board Treatment Plan · No Placebo Group · N/A
Age 12 - 39 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: